Some common heterocyclic compound, 67074-78-6, name is 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one, molecular formula is C7H7N3O, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. Computed Properties of C7H7N3O
A mixture of 3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-one (0.477 g), 4-methoxy-2-(4-(trifluoromethoxy)phenoxy)butanoic acid (0.883 g), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.690 g), 1-hydroxybenzotriazole monohydrate (0.551 g) and N,N-dimethylformamide (15 mL) was stirred at room temperature for 2 hr. To the reaction mixture was added water, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate) to give the title compound (1.09 g). 1H NMR (300 MHz, DMSO-d6) delta 1.75-2.04 (2H, m), 3.03 (3H, s), 3.23-3.46 (2H, m), 4.25 (1H, d, J = 16.6 Hz), 4.63 (1H, d, J = 16.6 Hz), 6.15 (1H, dd, J = 7.5, 4.1 Hz), 6.94-7.08 (2H, m), 7.28 (3H, dt, J = 8.3, 2.1 Hz), 7.42 (1H, dd, J = 7.9, 1.9 Hz), 8.07 (1H, dd, J = 4.7, 1.7 Hz), 10.89 (1H, brs).
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 67074-78-6, its application will become more common.
Reference:
Patent; Takeda Pharmaceutical Company Limited; NAKAMURA, Shinji; MIKAMI, Satoshi; KAWASAKI, Masanori; NOMURA, Izumi; ASHIZAWA, Tomoko; TANIGUCHI, Takahiko; EP2873669; (2015); A1;,
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics